Long-term antibody dynamics challenge the paradigm of lifelong homotypic immunity to dengue virus
Open Access
- 27 May 2026
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (22)
Abstract
Immunity following infection with the four dengue virus serotypes (DENV1-4) remains difficult to define. Reports of individuals being reinfected with the same serotype challenge the paradigm that infection induces lifelong homotypic immunity. However, the frequency of these events and their importance for shaping immune profiles remain unknown. Here, we used data from three cohorts (N = 4,268 total participants) in two highly endemic settings (Cebu, Philippines, and Kamphaeng Phet, Thailand), which included long-term follow-up of individuals (mean follow-up of 8.8, 1.9, and 5.0 y). These data allowed us to elucidate age-specific patterns of infection and immunity, and to quantify individual long-term antibody titer dynamics following infection. We formulated mathematical models to explain these patterns, allowing for the possibility of progressive loss of immunity to homotypic reinfection. At the individual level, we found that, in the absence of subsequent infection, antibody titers exhibit a steady long-term decay following incident infections (half-life of 7 to 8 y), with the rate of decay slowing with increasing age. At the population level, incorporating homotypic reinfection was required to explain the age-specific dynamics of infection and immunity observed in our cohorts. We estimated that in highly endemic settings such as the Philippines, 60% of individuals have been homotypically reinfected by the age of 40 y. Our findings highlight homotypic reinfections as a key feature of endemic DENV settings and suggest that vaccines mimicking natural infection might not be expected to provide lifelong protection against infection.Keywords
Funding Information
- US NIH (P01 AI034533)
- Military Infectious Disease Research Program (MIDRP)
- European Research Council (804744)
- Herchel Smith Postdoctoral Fellowship (HSPF)
This publication has 29 references indexed in Scilit:
- Household immunity and individual risk of infection with dengue virus in a prospective, longitudinal cohort studyNature Microbiology, 2023
- Achieving zero deaths from dengue virus under evolving population immunityThe Lancet Infectious Diseases, 2023
- Homotypic protection against influenza in a pediatric cohort in Managua, NicaraguaNature Communications, 2022
- Evaluation of the extended efficacy of the Dengvaxia vaccine against symptomatic and subclinical dengue infectionNature Medicine, 2021
- Waning immunity and re-emergence of measles and mumps in the vaccine eraCurrent Opinion in Virology, 2020
- Reconstruction of antibody dynamics and infection histories to evaluate dengue riskNature, 2018
- Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and MexicoCell, 2017
- The global burden of dengue: an analysis from the Global Burden of Disease Study 2013The Lancet Infectious Diseases, 2016
- Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine stormsNature Reviews Immunology, 2011
- DengueThe Lancet, 2007